GNPX

Genprex, Inc. GNPX

GNPX
Genprex, Inc. AIM
AIM ImmunoTech Inc. AYTU
Aytu BioPharma, Inc. COCP
Cocrystal Pharma, Inc. CODX
Co-Diagnostics, Inc. CRDF
Cardiff Oncology, Inc. DARE
Daré Bioscience, Inc. EFTR
eFFECTOR Therapeutics, Inc. NAVB
Navidea Biopharmaceuticals, Inc. PDSB
PDS Biotechnology Corporation

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GNPX AIM AYTU COCP CODX CRDF DARE EFTR NAVB PDSB
6M -23.04 % -16.00 % 126.92 % -10.16 % 2.71 % -10.53 % -27.89 % 0.00 % -83.33 % -8.03 %
YTD -77.23 % -88.55 % 38.82 % -50.43 % -47.55 % -48.12 % -34.16 % 19 900.00 % 0.00 % -45.24 %
1Y -39.99 % -90.31 % 4.42 % -35.75 % -71.29 % -15.97 % -39.94 % -99.38 % -80.00 % -71.12 %
3Y -99.62 % -94.75 % -30.59 % -53.82 % -89.01 % 36.42 % -80.80 % -100.00 % -99.96 % -76.49 %
5Y -99.87 % -98.94 % -98.84 % -90.12 % -97.41 % -85.82 % -83.64 % -100.00 % -100.00 % -61.65 %
10Y -99.89 % -99.97 % -100.00 % -99.56 % -93.48 % -99.41 % -99.48 % -100.00 % -100.00 % -99.79 %
From the beginning -99.89 % -72.52 % -100.00 % -99.87 % -93.48 % -99.86 % -99.74 % -100.00 % -100.00 % -99.57 %

Dividend